Sarepta Gets Thumbs Down From Regulators Regarding Elevidys Gene Therapy

benzinga.com/analyst-stock-ratings/analyst-color/25/07/46634492/sarepta-gets-thumbs-down-from-regulators-regarding-elevidys-gene-therapy

On Friday, the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) issued a negative opinion on the conditional marketing authorisation (CMA) for Elevidys (delandistrogene moxeparvovec) for ambulatory individuals aged three to seven years with…

This story appeared on benzinga.com, 2025-07-25 15:09:35.
The Entire Business World on a Single Page. Free to Use →